Dr. Michael Lanuti is the Director of Thoracic Oncology and the thoracic surgery liaison to the Massachusetts General Hospital Cancer Center in Boston, Massachusetts. His clinical interests include minimally invasive surgery for lung cancer and other thoracic malignancies including malignant pleural mesothelioma, as well as multimodality treatment of esophageal cancer, advanced staging procedures, complex airway
Dr. Hugh Auchincloss is a thoracic surgeon who practices at Massachusetts General Hospital in Boston. He also sees patients at Newton-Wellesley Hospital in Newton, Massachusetts. Dr. Auchincloss uses minimally invasive and robotic approaches to treat patients diagnosed with lung cancer, esophageal cancer, malignant pleural mesothelioma, esophageal cancer, gastroesophageal reflux, and tumors of the mediastinum. His
Dr. Henning Gaissert is a thoracic surgeon at Massachusetts General Hospital in Boston, Massachusetts, and leads its department at Newton-Wellesley Hospital in Newton, Massachusetts. He has extensive experience in the use of traditional open surgery and minimally invasive surgical techniques for the treatment of lung cancer, malignant pleural mesothelioma, and other thoracic malignancies. In addition
Dr. Andrew Haas is a pulmonologist and Associate Professor of Medicine in Pulmonary, Allergy, and Critical Care Medicine at the Hospital of the University of Pennsylvania, as well as the Bronchoscopy Director and Director of the Interventional Pulmonary and Thoracic Oncology Program. His clinical expertise in interventional pulmonary and thoracic oncology has made him a
Dr. Matthew J. Schuchert is a thoracic and cardiothoracic surgeon at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. He is a member of both the Department of Cardiothoracic Surgery and the Division of Thoracic and Foregut Surgery and dedicates much of his practice to the care of patients with lung cancer and other
Dr. David C. Rice is a thoracic and cardiovascular surgeon and Professor in Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. His focus is on providing the best and most modern surgical care possible to patients with thoracic malignancies like pleural mesothelioma and lung cancer. As a thoracic surgeon, he
Dr. Charles B. Simone is a radiation oncologist and specialist in the use of proton and photon radiation therapy and photodynamic therapy at Memorial Sloan Kettering Cancer Center in New York City and the New York Proton Center, where he is Chief Medical Officer. Dr. Simone treats patients with malignant pleural mesothelioma, lung cancer, and
Dr. Erin A. Gillaspie is a thoracic surgeon. She is the Chief of Thoracic Surgery at Creighton University Medical Center in Omaha, Nebraska, where she provides advanced surgical treatment for patients diagnosed with malignant pleural mesothelioma, lung cancer, and other thoracic malignancies. Inspired to become a thoracic surgeon by her own grandfather’s diagnosis of malignant
Dr. Lorraine D. Cornwell is a thoracic and cardiothoracic surgeon at the Michael E. DeBakey VA Medical Center in Houston, Texas. Her practice is directed toward providing state-of-the-art thoracic oncologic and cardiac surgical services to the country’s military veterans diagnosed with an array of diseases and conditions, including asbestos-related lung cancer and malignant pleural mesothelioma.
Malignant mesothelioma is challenging for numerous reasons. Always fatal, mesothelioma remains latent for decades before appearing in an aggressive and fast-moving way. Making matters worse, the condition’s rarity limits scientists’ ability to test new treatments. To address this, Australian researchers have explored using pleural effusion samples from patients to create models called “organoids” on which